Second Primary Cancer After Chimeric Antigen Receptor–T-Cell Therapy

Overview of attention for article published in JAMA Oncology, February 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

news: 3 news outlets
twitter: 43 X users

facebook: 1 Facebook page
bluesky: 5 Bluesky users

Readers on

mendeley: 15 Mendeley

So far, Altmetric has seen 46 X posts from 43 X users, with an upper bound of 152,248 followers.

RT @JAMAOnc: Chimeric antigen receptor–T-cell (CAR-T) therapy has revolutionized the treatment of hematologic cancers. This review discusse…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 42 additional X posts.